Cynomolgus monkey (pivotal); mouse surrogate muS757 for EFD and 1-month study
“The cynomolgus monkey was selected for toxicology testing given that tarlatamab similarly bound human and monkey CD3 and DLL3 but did not bind CD3 from other species.”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗
Why that species
Similar binding to human and monkey CD3 and DLL3; no binding to rodent, rabbit, dog, minipig T cells; DLL3 intracellular in normal tissue limits relevance
“However, the monkey may not be pharmacologically relevant considering DLL3 is expressed intracellularly in normal cells and tissues.”
✓ VerifiedFDA multi-discipline review, p. 48Source ↗
Surrogate molecule
Yes: murine surrogate muS757 (binds mouse DLL3 and CD3) for 1-month mouse tox and EFD study
“Following the proposal of the FDA, a murine surrogate molecule of tarlatamab, designated muS757, was developed to evaluate potential effects of a DLL3-targeting BiTE molecule on embryofetal development in mice.”
✓ VerifiedFDA multi-discipline review, p. 65Source ↗